{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:23:18Z","timestamp":1791440598947,"version":"4.3.3"},"reference-count":39,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Assoc Provid AIDS Care"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>: Dolutegravir (DTG)-based antiretroviral therapy (ART) use has been associated with excessive weight gain, increasing the risk of dyslipidemias such as hypercholesterolemia. We assessed the prevalence of, and associated factors with dyslipidemia among adults on DTG-based ART.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We conducted a cross-sectional study among 281 systematically sampled adults on DTG-based ART for \u2265\u20096 months at Kira Health Centre IV, Wakiso District, Central Uganda. Data were collected through structured questionnaires, medical record reviews, anthropometric measurements, and laboratory biomarker analysis. Logistic regression was used to determine associated factors, and the predictive performance of obesity indices was evaluated using receiver operating characteristic (ROC) curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of dyslipidemia was 44.1% 95% CI: 38.4%\u201350.0%. Low high-density lipoprotein (HDL) cholesterol was the most common abnormality, affecting 39.9% of participants, followed by elevated total cholesterol at 5.7% [95% CI: 3.51\u20139.11] and elevated low-density lipoprotein (LDL) cholesterol at 5.0%. High waist circumference (WC) was significantly associated with dyslipidemia; (aPR: 1.93, 95% CI: 1.15\u20133.24,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u2009.013), and demonstrated a significant ability to predict dyslipidemia with area under the curve (AUC) of 0.577 [95% CI: 0.511\u20130.644]. The AUC for WC in predicting hypercholesterolemia, elevated LDL-C, and low HDL-C were 0.702 (95% CI: 0.547\u20130.857), 0.729(95% CI: 0.590\u20130.867), and 0.548 (95% CI: 0.481\u20130.616) respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Dyslipidemia is prevalent among adults on DTG-based ART, and is potentially associated with high WC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/23259582251395549","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T17:01:16Z","timestamp":1762966876000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Dyslipidemia and Associated Factors Among People Living With HIV on Dolutegravir-Based Antiretroviral Therapy in Central Uganda"],"prefix":"10.1177","volume":"24","author":[{"given":"Flavia","family":"Timbigamba","sequence":"first","affiliation":[{"name":"Mbarara University of Science and Technology"},{"name":"Department of Medical Laboratory Science, Uganda Institute of Allied Health and Management Sciences, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4235-1003","authenticated-orcid":false,"given":"Charles Nkubi","family":"Bagenda","sequence":"additional","affiliation":[{"name":"Mbarara University of Science and Technology"},{"name":"Department of Medical Laboratory Science, Uganda Institute of Allied Health and Management Sciences, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendry","family":"Sembogga","sequence":"additional","affiliation":[{"name":"Mbarara University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Wasswa","sequence":"additional","affiliation":[{"name":"Mbarara University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizo","family":"Bazibu","sequence":"additional","affiliation":[{"name":"Mbarara University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ssali","sequence":"additional","affiliation":[{"name":"Mbarara University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elastus","family":"Ssemwanga","sequence":"additional","affiliation":[{"name":"Mayanja Memorial Medical Training Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3947-3864","authenticated-orcid":false,"given":"Michael Junior","family":"Mugisa","sequence":"additional","affiliation":[{"name":"Mbarara University of Science and Technology"},{"name":"Mayanja Memorial Medical Training Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Nuwagaba","sequence":"additional","affiliation":[{"name":"Neocare Specialised Hospital and Fertility Centre Plot 1c Johnstone Road"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Ojuko","sequence":"additional","affiliation":[{"name":"Soroti University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Nantongo","sequence":"additional","affiliation":[{"name":"Mbarara University of Science and Technology"},{"name":"Department of Medical Laboratory, Joint Clinical Research Centre, Gulu City, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesca Akoth","family":"Wafwoyo","sequence":"additional","affiliation":[{"name":"Mbarara University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1211-4617","authenticated-orcid":false,"given":"Benson","family":"Musinguzi","sequence":"additional","affiliation":[{"name":"Muni University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Akiteng","sequence":"additional","affiliation":[{"name":"Muni University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence Obado","family":"Osuwat","sequence":"additional","affiliation":[{"name":"Soroti University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"e_1_3_4_2_2","unstructured":"Global H. AIDS statistics\u2014Fact sheet| UNAIDS. Dostopno na: https:\/\/www unaidsorg\/en\/resources\/fact-sheetPridobljeno. 2021."},{"issue":"3","key":"e_1_3_4_3_2","first-page":"296","article-title":"The global HIV\/AIDS epidemic. 2021","volume":"11","author":"UNAIDS","year":"2021","unstructured":"UNAIDS. The global HIV\/AIDS epidemic. 2021. J Epidemiol Glob Health. 2021;11(3):296-301.","journal-title":"J Epidemiol Glob Health."},{"key":"e_1_3_4_4_2","volume-title":"News & events updates","author":"MoH","year":"2020","unstructured":"MoH. News & events updates. Uganda AIDS Commission; 2020."},{"key":"e_1_3_4_5_2","volume-title":"GBD 2019 cause and risk summaries","author":"IHME","year":"2019","unstructured":"IHME. GBD 2019 cause and risk summaries. Uganda; 2019."},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000496"},{"key":"e_1_3_4_7_2","article-title":"WHO recommends dolutegravir as preferred HIV treatment option in all populations","volume":"22","author":"WHO","year":"2019","unstructured":"WHO. WHO recommends dolutegravir as preferred HIV treatment option in all populations. News Release. 2019;22.","journal-title":"News Release"},{"key":"e_1_3_4_8_2","unstructured":"Ministry of Health U. 2020. Consolidated guidelines for the prevention and treatment of HIV and AIDS in Uganda."},{"issue":"1","key":"e_1_3_4_9_2","article-title":"Low aspartate aminotransferase\/alanine aminotransferase ratio as an indicator of metabolic syndrome among HIV patients on dolutegravir therapy in southwestern uganda","volume":"17","author":"Nzaramba D","year":"2025","unstructured":"Nzaramba D, Bagenda CN, Mudondo H, et al. Low aspartate aminotransferase\/alanine aminotransferase ratio as an indicator of metabolic syndrome among HIV patients on dolutegravir therapy in southwestern uganda. Cureus. 2025;17(1).","journal-title":"Cureus"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/20503121231196701"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.2147\/IBPC.S403023"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08892-8"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002811"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904340"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902824"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2295435"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-023-00510-6"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/09564624221129410"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S59852"},{"key":"e_1_3_4_20_2","unstructured":"Ministry of Health DoPaNMD. Uganda Clinical Guidelines 2023. 2024; https:\/\/library.health.go.ug\/uganda-clinical-guidelines-2023 (accessed 10 February 2025)."},{"issue":"2","key":"e_1_3_4_21_2","first-page":"83","article-title":"Assessment of physical activity by applying IPAQ questionnaire","volume":"52","author":"Biernat E","year":"2008","unstructured":"Biernat E, Stupnicki R, Lebiedzi\u0144ski B, Janczewska L. Assessment of physical activity by applying IPAQ questionnaire. Physical Education and Sport. 2008;52(2):83-89.","journal-title":"Physical Education and Sport"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-0903"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.18209"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11342"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.7570\/kjo.2016.25.3.115"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0273786"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.048996"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwh090"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08587-0"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247004"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223189"},{"key":"e_1_3_4_32_2","unstructured":"WHO. 2014 WHO STEPS survey. 2014; https:\/\/cdn.who.int\/media\/docs\/default-source\/ncds\/ncd-surveillance\/data-reporting\/uganda\/steps\/uganda_2014_steps_factsheet.pdf?sfvrsn=f54d6c23_3#:\u223c:text=Percentage%20with%20raised%20total%20cholesterol 7.8."},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126166"},{"key":"e_1_3_4_34_2","first-page":"19","article-title":"Dyslipidaemia among antiretroviral therapy-experienced adolescents and young people living with HIV in Lagos, Nigeria","volume":"6","author":"Abike G-BT","year":"2021","unstructured":"Abike G-BT, Olaseni OO, Olurotimi SA, et al. Dyslipidaemia among antiretroviral therapy-experienced adolescents and young people living with HIV in Lagos, Nigeria. Int Res J Med Biomed Sci. 2021;6(3):19\u201327.","journal-title":"Int Res J Med Biomed Sci"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2020.100217"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08910-9"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270838"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S319161"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1177\/20480040221114651"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024800"}],"container-title":["Journal of the International Association of Providers of AIDS Care (JIAPAC)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23259582251395549","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23259582251395549","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23259582251395549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:50:47Z","timestamp":1777503047000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/23259582251395549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":39,"alternative-id":["10.1177\/23259582251395549"],"URL":"https:\/\/doi.org\/10.1177\/23259582251395549","relation":{},"ISSN":["2325-9582","2325-9582"],"issn-type":[{"value":"2325-9582","type":"print"},{"value":"2325-9582","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]},"article-number":"23259582251395549"}}